Ground Fluor Pharmaceuticals
Lincoln, Nebraska, United States · Founded 2012
About Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals developed new chemistry technology which transforms complicated and costly fluorine syntheses into simpler, more efficient processes. Using technology developed at the University of Nebraska and the Massachusetts General Hospital and funded by the National Science Foundation and Cedarville Investments, Ltd., GFP has developed and patented processes and intermediate chemicals for the efficient, cost-effective production of PET imaging agents.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: M&A
- Last round: Grant (Apr 2014)
- Website: http://www.gfpharma.com
- Phone: +1 (402)875-0055
Industries & Categories
Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/ground-fluor-pharmaceuticals-2468208 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.